Neuphoria Therapeutics Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Neuphoria Therapeutics Inc. reported Cash And Cash Equivalents At Carrying Value of $14.21 million for the year ending 2025.

  • Neuphoria Therapeutics Inc. showed an increase of +12.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Neuphoria Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Neuphoria Therapeutics Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 17.4%.
  • Historical annual values: Fiscal year 2025: $14.21 million | Fiscal year 2024: $12.61 million | Fiscal year 2023: $12.10 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: